Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK105056A1, R03DK106451 and K08DK089015)
The Children’s Discovery Institute of Washington University and St. Louis Children's Hospital (Faculty Scholar Award (MD-FR-2013-336))
Halpin Foundation-American Society of Nephrology
Doris Duke Charitable Foundation (Clinical Scientist Development Award (2015100))
Nephrotic Syndrome Study Network (Career Development Award)
The Central Society for Clinical and Translational Research (Early Career Development Award)
Washington University Division of Nephrology (Renal Translational Innovation Grant)
Article History
Received: 6 April 2018
Revised: 22 June 2018
Accepted: 20 July 2018
First Online: 11 August 2018
Compliance with ethical standards
:
: A patent application entitled “Mesencephalic astrocyte-derived neurotrophic factor (MANF) as a urine biomarker for endoplasmic reticulum (ER) stress-related kidney disease, methods and uses therefore” has been filed by Y.M. Chen and Washington University Office of Technology Management (serial no. 14730465, filed on June 4, 2015). Another patent application entitled “Methods of detecting biomarkers of endoplasmic reticulum (ER) stress-associated kidney diseases” has been filed by Y.M. Chen and Y. Kim and Washington University Office of Technology Management (serial no. 15664476, filed on July 31, 2017).